Jemna N, Zdrenghea AC, Frunza G, Demea AD, Hapca GE, Grad DA, Muresanu IA,
Chereches RM, Muresanu FD. Theta-burst stimulation as a therapeutic tool in
neurological pathology: a systematic review. Neurol Sci. 2024 Mar;45(3):911-940.
doi: 10.1007/s10072-023-07144-6. Epub 2023 Oct 26. PMID: 37882997.

Dobran SA, Gherman A, Muresanu D. Insights into Swallowing Disorders: the
Dysphagia Course Series. J Med Life. 2023 Dec;16(12):1714-1716. doi:
10.25122/jml-2023-1032. PMID: 38585519; PMCID: PMC10994618.

Dobran SA, Gherman A, Mureşanu D. Unveiling the Future of
Neurorehabilitation: Insights from the 18^th Congress from the Society
for the Study of Neuroprotection and Neuroplasticity (SSNN) in Conjunction with
the WFNR-EFNR Central Asia Regional Meeting. J Med Life. 2023
Dec;16(12):1717-1722. doi: 10.25122/jml-2023-1033. PMID: 38585518; PMCID:
PMC10994616.

Popa LL, Chira D, Strilciuc Ș, Mureșanu DF. Non-Invasive Systems Application
in Traumatic Brain Injury Rehabilitation. Brain Sci. 2023 Nov 15;13(11):1594.
doi: 10.3390/brainsci13111594. PMID: 38002552; PMCID: PMC10670234.

Drăghici NC, Văcăraș V, Bolchis R, Bashimov A, Domnița DM, Iluț S, Popa LL,
Lupescu TD, Mureșanu DF. Diagnostic Approach to Lower Limb Entrapment
Neuropathies: A Narrative Literature Review. Diagnostics (Basel). 2023 Nov
4;13(21):3385. doi: 10.3390/diagnostics13213385. PMID: 37958280; PMCID:
PMC10647627.

Dobran SA, Gherman A, Mureşanu D. 18^th International Summer School
of Neurology in conjunction with the 13^th European Teaching Course on
Neurorehabilitation. J Med Life. 2023 Nov;16(11):1582-1584. doi:
10.25122/jml-2023-1031. PMID: 38406791; PMCID: PMC10893578.

Andriescu C, Gherman A, Dobran SA, Muresanu D. Mindscapes of
Neurorehabilitation: Insights from the European Congress on Neurorehabilitation
2023 - Part II. J Med Life. 2023 Nov;16(11):1579-1581. doi:
10.25122/jml-2023-1030. PMID: 38406778; PMCID: PMC10893577.

Andriescu C, Gherman A, Dobran SA, Muresanu D. Mindscapes of
Neurorehabilitation: Insights from the European Congress on Neurorehabilitation
2023 - Part I. J Med Life. 2023 Oct;16(10):1436-1438. doi:
10.25122/jml-2023-1029. PMID: 38313172; PMCID: PMC10835545.

Wang R, Muresanu D, Hösl K, Hilz MJ. Cardiovascular autonomic regulation
correlates with cognitive performance in patients with a history of traumatic
brain injury. Neurol Sci. 2023 Oct;44(10):3535-3544. doi:
10.1007/s10072-023-06857-y. Epub 2023 May 25. PMID: 37227563; PMCID:
PMC10495484.

Dobran SA, Livint Popa L, Muresanu D. Fractured Minds: A chronicle of
neurotrauma in the 18^th century. J Med Life. 2023
Sep;16(9):1297-1298. doi: 10.25122/jml-2023-1028. PMID: 38107715; PMCID:
PMC10719782.Livinț Popa L, Chelaru VF, Dăbală V, Chertic D, Vlad I, Dragoș HM, Mureșanu
D. Continuity in the Educational Approach: Neurotech^EU Summer School
of Quantitative Electroencephalography (QEEG) Second Edition in Cluj-Napoca. J
Med Life. 2023 Aug;16(8):1159-1164. doi: 10.25122/jml-2023-1027. PMID: 38024825;
PMCID: PMC10652687.

Andrade CAS, Mahrouseh N, Gabrani J, Charalampous P, Cuschieri S, Grad DA,
Unim B, Mechili EA, Chen-Xu J, Devleesschauwer B, Isola G, von der Lippe E,
Baravelli CM, Fischer F, Weye N, Balaj M, Haneef R, Economou M, Haagsma JA,
Varga O. Inequalities in the burden of non-communicable diseases across European
countries: a systematic analysis of the Global Burden of Disease 2019 study. Int
J Equity Health. 2023 Jul 28;22(1):140. doi: 10.1186/s12939-023-01958-8. PMID:
37507733; PMCID: PMC10375608.

Ionescu A, Ștefănescu E, Strilciuc Ș, Rafila A, Mureșanu D. Correlating Eye-
Tracking Fixation Metrics and Neuropsychological Assessment after Ischemic
Stroke. Medicina (Kaunas). 2023 Jul 25;59(8):1361. doi:
10.3390/medicina59081361. PMID: 37629651; PMCID: PMC10456465.

Iluț S, Vesa ŞC, Văcăraș V, Brăiță L, Dăscălescu VC, Fantu I, Mureșanu DF.
Biological Risk Factors Influencing Vascular Cognitive Impairments: A Review of
the Evidence. Brain Sci. 2023 Jul 19;13(7):1094. doi: 10.3390/brainsci13071094.
PMID: 37509024; PMCID: PMC10377134.

Rafila A, Blidaru T, Garofil D, Strilciuc S, Muresanu DF. Addressing the
Healthcare Crisis - The Bucharest High-level Regional Meeting on Health and Care
Workforce in Europe: TIME TO ACT. J Med Life. 2023 Jul;16(7):963-966. doi:
10.25122/jml-2023-1024. PMID: 37900078; PMCID: PMC10600671.

Paun AGE, Chifor R, Radu C, Strilciuc Ş, Badea IC, Borzan CM. Oral health,
the patients' perspective during the COVID 19 pandemic. Med Pharm Rep. 2023
Jul;96(3):305-309. doi: 10.15386/mpr-2553. Epub 2023 Jul 27. PMID: 37577022;
PMCID: PMC10419691.

Iluţ S, Vesa ŞC, Văcăraș V, Mureșanu DF. Predictors of Short-Term Mortality
in Patients with Ischemic Stroke. Medicina (Kaunas). 2023 Jun 13;59(6):1142.
doi: 10.3390/medicina59061142. PMID: 37374346; PMCID: PMC10304635.

Verisezan Rosu O, Jemna N, Hapca E, Benedek I, Vadan I, Muresanu I, Chira D,
Radu C, Cherecheş R, Strilciuc S, Muresanu D. Cerebrolysin and repetitive
transcranial magnetic stimulation (rTMS) in patients with traumatic brain
injury: a three-arm randomized trial. Front Neurosci. 2023 Jun 8;17:1186751.
doi: 10.3389/fnins.2023.1186751. PMID: 37360156; PMCID: PMC10285097.

Chira D, Muresanu D. Continuing the Journey: The Second Edition of the
Neurotrauma Treatment Simulation Center (NTSC). J Med Life. 2023
Jun;16(6):810-815. doi: 10.25122/jml-2023-1022. PMID: 37675171; PMCID:
PMC10478650.

Gherman A, Strilciuc A. Professor Johannes Vester, President of the Academy
for Multidisciplinary Traumatology: Adapted Interview from the 20^th
AMN Congress (May 12-13), Krakow, Poland. J Med Life. 2023 Jun;16(6):816-817.
doi: 10.25122/jml-2023-1023. PMID: 37675164; PMCID: PMC10478656.

Dobran SA, Gherman A, Muresanu D. The Academy for Multidisciplinary
Neurotraumatology (AMN) Congress 2023: 20 Years of Excellence in
Neurotraumatology. J Med Life. 2023 Jun;16(6):806-809. doi:
10.25122/jml-2023-1021. PMID: 37675162; PMCID: PMC10478668.

Sharma HS, Feng L, Chen L, Huang H, Ryan Tian Z, Nozari A, Muresanu DF,
Lafuente JV, Castellani RJ, Wiklund L, Sharma A. Cerebrolysin Attenuates
Exacerbation of Neuropathic Pain, Blood-spinal Cord Barrier Breakdown and Cord
Pathology Following Chronic Intoxication of Engineered Ag, Cu or Al (50-60 nm)
Nanoparticles. Neurochem Res. 2023 Jun;48(6):1864-1888. doi:
10.1007/s11064-023-03861-8. Epub 2023 Jan 31. PMID: 36719560; PMCID:
PMC10119268.

Strilciuc S, Radu C, Grad DA, Stan AD, Vladescu C, Buzoianu AD, Muresanu D.
Cost-Effectiveness of Cerebrolysin after Ischemic Stroke: Secondary Analysis of
the CARS Study. Healthcare (Basel). 2023 May 21;11(10):1497. doi:
10.3390/healthcare11101497. PMID: 37239783; PMCID: PMC10218347.

Crișan CA, Milhem Z, Stretea R, Hossu RM, Florean IS, Cherecheș RM. Coping
Mechanisms during the War in Ukraine: A Cross-Sectional Assessment among
Romanian Population. Healthcare (Basel). 2023 May 13;11(10):1412. doi:
10.3390/healthcare11101412. PMID: 37239702; PMCID: PMC10218351.

Dobran SA, Gherman A, Muresanu D. The National Neurology Forum 2023:
Patients, Doctors, Authorities, Industry - Together for the Future of Neurology.
J Med Life. 2023 May;16(5):635-637. doi: 10.25122/jml-2023-1020. PMID: 37520475;
PMCID: PMC10375345.

Ionescu A, Ştefănescu E, Strilciuc Ş, Grad DA, Mureşanu D. Eyes on dementia:
an overview of the interplay between eye movements and cognitive decline. J Med
Life. 2023 May;16(5):642-662. doi: 10.25122/jml-2023-0217. PMID: 37520470;
PMCID: PMC10375353.

Tiu C, Grad DA, Muresanu D. Romanian registry for interventional treatment
in acute stroke: a hope for secondary prevention through medication adherence
improvement. J Med Life. 2023 Apr;16(4):481-482. doi: 10.25122/jml-2023-1015.
PMID: 37305838; PMCID: PMC10251378.

Dobran SA, Gherman A. Professor Matilde Leonardi, Fondazione IRCCS Istituto
Neurologico Besta, Milan, Italy: Adapted Interview from the 12^th
World Congress for NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023
Apr;16(4):485-486. doi: 10.25122/jml-2023-1017. PMID: 37305834; PMCID:
PMC10251390.

Dobran SA, Gherman A. Professor Karin Diserens, WFNR chair of the Special
Interest Group on Early Mobilization and member of the executive committee of
the EFNR Health & Economics: Adapted Interview from the 12^th World
Congress for Neurorehabilitation (WCNR), Vienna, 2022. J Med Life. 2023
Apr;16(4):489-490. doi: 10.25122/jml-2023-1019. PMID: 37305833; PMCID:
PMC10251376.

Dobran SA, Gherman A. Dr. Wayne Feng, Professor of Biomedical Engineering,
Pratt School of Engineering, Duke University, United States: Adapted Interview
from the 12^th World Congress for NeuroRehabilitation (WCNR), Vienna,
2022. J Med Life. 2023 Apr;16(4):483-484. doi: 10.25122/jml-2023-1016. PMID:
37305824; PMCID: PMC10251374.

Constantinescu AD, Gherman A. Professor Jorge Hernández Franco, Instituto
Nacional de Neurología y Neurocirugía Manuel Velasco Suárez (INNN, Mexico City,
Mexico): Adapted Interview from the 12^th World Congress for
NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023 Apr;16(4):487-488.
doi: 10.25122/jml-2023-1018. PMID: 37305816; PMCID: PMC10251386.

Constantinescu AD, Gherman A. Professor David Good, Past President of the
World Federation for NeuroRehabilitation: Adapted Interview from the
12^th World Congress for NeuroRehabilitation (WCNR), Vienna, 2022. J
Med Life. 2023 Mar;16(3):337-338. doi: 10.25122/jml-2023-1013. PMID: 37168311;
PMCID: PMC10165526.

Mosca I, Radu C, Strilciuc Ș, Ungureanu MI. A five-year (2017-2021) time
series evaluation of patient-reported informal healthcare payments in Romania. J
Med Life. 2023 Mar;16(3):387-393. doi: 10.25122/jml-2023-0080. PMID: 37168305;
PMCID: PMC10165521.

Dobran SA, Gherman A. Dr. Michael H. Thaut, Ph.D., Professor of Music at the
University of Toronto, Canada: Adapted Interview from the 12^th World
Congress for NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023
Mar;16(3):339-340. doi: 10.25122/jml-2023-1014. PMID: 37168302; PMCID:
PMC10165520.

Dobran SA, Gherman A. Professor Mayowa Owolabi, WFNR Regional Vice-President
for Africa: Adapted Interview from the 12^th World Congress for
NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023 Mar;16(3):334-336.
doi: 10.25122/jml-2023-1012. PMID: 37168299; PMCID: PMC10165530.

Dobran SA, Gherman A, Muresanu D. EFNR-WFNR Eastern Europe Regional Meeting
in conjunction with the Bistrița Clinical Neuroscience Conference: European
Perspectives in Neurorehabilitation. J Med Life. 2023 Mar;16(3):331-333. doi:
10.25122/jml-2023-1011. PMID: 37168297; PMCID: PMC10165512.

Dragoș HM, Stan A, Pintican R, Feier D, Lebovici A, Panaitescu PȘ, Dina C,
Strilciuc S, Muresanu DF. MRI Radiomics and Predictive Models in Assessing
Ischemic Stroke Outcome-A Systematic Review. Diagnostics (Basel). 2023 Feb
23;13(5):857. doi: 10.3390/diagnostics13050857. PMID: 36900001; PMCID:
PMC10000411.

Dobran SA, Gherman A. Professor Michael Barnes, Honorary Professor of
Neurological Rehabilitation, University of Newcastle, U.K.: Adapted Interview
from the 12^th World Congress for NeuroRehabilitation (WCNR), Vienna,
2022. J Med Life. 2023 Feb;16(2):178-179. doi: 10.25122/jml-2023-1005. PMID:
36937485; PMCID: PMC10015580.

Dobran SA, Gherman A. Professor Caterina Pistarini, Secretary General of the
World Federation for NeuroRehabilitation & EFNR Research and Education Affairs:
Adapted Interview from the 12^th World Congress for
NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023 Feb;16(2):182-183.
doi: 10.25122/jml-2023-1007. PMID: 36937481; PMCID: PMC10015570.Constantinescu AD, Gherman A. Professor Nirmal Surya, Neurologist at Bombay
Hospital & Saifee Hospital, Mumbai, India: Adapted Interview from the
12^th World Congress for NeuroRehabilitation (WCNR), Vienna, 2022. J
Med Life. 2023 Feb;16(2):180-181. doi: 10.25122/jml-2023-1006. PMID: 36937476;
PMCID: PMC10015582.

Constantinescu AD, Gherman A. Michael Chopp, Ph.D., Distinguished Professor
of Physics at Oakland University, Michigan, United States: Adapted Interview
from the 12^th World Congress for NeuroRehabilitation (WCNR), Vienna,
2022. J Med Life. 2023 Feb;16(2):184-185. doi: 10.25122/jml-2023-1008. PMID:
36937466; PMCID: PMC10015572.

Buzoianu AD, Sharma A, Muresanu DF, Feng L, Huang H, Chen L, Tian ZR, Nozari
A, Lafuente JV, Sjöqvist PO, Wiklund L, Sharma HS. Nanodelivery of histamine H3
receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor
agonist clobenpropit induced neuroprotection is potentiated by antioxidant
compound H-290/51 in spinal cord injury. Int Rev Neurobiol. 2023;172:37-77. doi:
10.1016/bs.irn.2023.06.003. Epub 2023 Sep 26. PMID: 37833018.

Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A,
Wiklund L, Sharma HS. Spinal cord injury induced exacerbation of Alzheimer's
disease like pathophysiology is reduced by topical application of nanowired
cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor
necrosis factor alpha. Int Rev Neurobiol. 2023;172:3-35. doi:
10.1016/bs.irn.2023.05.011. Epub 2023 Sep 26. PMID: 37833015.

Tian ZR, Sharma A, Muresanu DF, Sharma S, Feng L, Zhang Z, Li C, Buzoianu
AD, Lafuente JV, Nozari A, Sjöqvisst PO, Wiklund L, Sharma HS. Nicotine
neurotoxicity exacerbation following engineered Ag and Cu (50-60 nm)
nanoparticles intoxication. Neuroprotection with nanowired delivery of
antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist
ondansetron. Int Rev Neurobiol. 2023;172:189-233. doi:
10.1016/bs.irn.2023.07.002. Epub 2023 Sep 26. PMID: 37833012.

Wang ZG, Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD,
Nozari A, Huang H, Chen L, Manzhulo I, Wiklund L, Sharma HS. Co-administration
of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease
associated with mild traumatic brain injury. Int Rev Neurobiol.
2023;172:145-185. doi: 10.1016/bs.irn.2023.06.006. Epub 2023 Sep 26. PMID:
37833011.

Ozkizilcik A, Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu
AD, Nozari A, Wiklund L, Sharma HS. Nanowired delivery of antibodies to tau and
neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic
brain injury induced exacerbation of brain pathology in Parkinson's disease. Int
Rev Neurobiol. 2023;171:83-121. doi: 10.1016/bs.irn.2023.07.001. Epub 2023 Sep
15. PMID: 37783564.

Feng L, Sharma A, Wang Z, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD,
Nozari A, Li C, Zhang Z, Lin C, Huang H, Manzhulo I, Wiklund L, Sharma HS.
Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein
potentiated neuroprotection in Parkinson's disease with emotional stress. Int
Rev Neurobiol. 2023;171:47-82. doi: 10.1016/bs.irn.2023.06.005. Epub 2023 Jul
20. PMID: 37783563.

Sharma HS, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A,
Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma A. Stress induced exacerbation
of Alzheimer's disease brain pathology is thwarted by co-administration of
nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with
serotonin 5-HT6 receptor antagonist SB-399885. Int Rev Neurobiol. 2023;171:3-46.
doi: 10.1016/bs.irn.2023.05.018. Epub 2023 Sep 16. PMID: 37783559.

Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A,
Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Sleep deprivation enhances
amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects
of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta
peptide, p-tau and serotonin. Int Rev Neurobiol. 2023;171:125-162. doi:
10.1016/bs.irn.2023.05.009. Epub 2023 Sep 22. PMID: 37783554.

Ottonelli I, Sharma A, Ruozi B, Tosi G, Duskey JT, Vandelli MA, Lafuente JV,
Nozari A, Muresanu DF, Buzoianu AD, Tian ZR, Zhang Z, Li C, Feng L, Wiklund L,
Sharma HS. Nanowired Delivery of Curcumin Attenuates Methamphetamine
Neurotoxicity and Elevates Levels of Dopamine and Brain-Derived Neurotrophic
Factor. Adv Neurobiol. 2023;32:385-416. doi: 10.1007/978-3-031-32997-5_10. PMID:
37480467.

Wiklund L, Sharma A, Muresanu DF, Zhang Z, Li C, Tian ZR, Buzoianu AD,
Lafuente JV, Nozari A, Feng L, Sharma HS. TiO₂-Nanowired Delivery of
Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide BN-52021 Enhanced
Neuroprotective Effects of Cerebrolysin Following Spinal Cord Injury at Cold
Environment. Adv Neurobiol. 2023;32:353-384. doi: 10.1007/978-3-031-32997-5_9.
PMID: 37480466.

Lafuente JV, Sharma A, Feng L, Muresanu DF, Nozari A, Tian ZR, Buzoianu AD,
Sjöquist PO, Wiklund L, Sharma HS. Nanowired Delivery of Mesenchymal Stem Cells
with Antioxidant Compound H-290/51 Reduces Exacerbation of Methamphetamine
Neurotoxicity in Hot Environment. Adv Neurobiol. 2023;32:317-352. doi:
10.1007/978-3-031-32997-5_8. PMID: 37480465.

Nozari A, Sharma A, Wang Z, Feng L, Muresanu DF, Tian ZR, Lafuente JV,
Buzoianu AD, Wiklund L, Sharma HS. Co-administration of Nanowired Oxiracetam and
Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted
Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment.
Adv Neurobiol. 2023;32:271-313. doi: 10.1007/978-3-031-32997-5_7. PMID:
37480464.

Muresanu DF, Sharma A, Tian ZR, Lafuente JV, Nozari A, Feng L, Buzoianu AD,
Wiklund L, Sharma HS. Nanowired Delivery of Cerebrolysin with Mesenchymal Stem
Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following
Brain Blast Injury. Adv Neurobiol. 2023;32:231-270. doi:
10.1007/978-3-031-32997-5_6. PMID: 37480463.

Sharma A, Muresanu DF, Tian ZR, Nozari A, Lafuente JV, Buzoianu AD, Sjöquist
PO, Feng L, Wiklund L, Sharma HS. Co-Administration of Nanowired Monoclonal
Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha
Together with Antioxidant H-290/51 Reduces SiO₂ Nanoparticles-Induced
Exacerbation of Pathophysiology of Spinal Cord Trauma. Adv Neurobiol.
2023;32:195-229. doi: 10.1007/978-3-031-32997-5_5. PMID: 37480462.

Sharma HS, Muresanu DF, Nozari A, Lafuente JV, Buzoianu AD, Tian ZR, Huang
H, Feng L, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma A. Neuroprotective
Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and
Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology
Following Alzheimer's Disease Exacerbated by Concussive Head Injury. Adv
Neurobiol. 2023;32:139-192. doi: 10.1007/978-3-031-32997-5_4. PMID: 37480461.

Feng L, Sharma A, Wang Z, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD,
Nozari A, Wiklund L, Sharma HS. Co-administration of Nanowired
DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal
Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance
Superior Neuroprotection in Parkinson's Disease Following Concussive Head
Injury. Adv Neurobiol. 2023;32:97-138. doi: 10.1007/978-3-031-32997-5_3. PMID:
37480460.

Buzoianu AD, Sharma A, Muresanu DF, Feng L, Huang H, Chen L, Tian ZR, Nozari
A, Lafuente JV, Wiklund L, Sharma HS. Nanodelivery of Histamine H3/H4 Receptor
Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in
Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson's Disease.
Adv Neurobiol. 2023;32:55-96. doi: 10.1007/978-3-031-32997-5_2. PMID: 37480459.

Sharma A, Feng L, Muresanu DF, Tian ZR, Lafuente JV, Buzoianu AD, Nozari A,
Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Nanowired Delivery of
Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated
Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in
Alzheimer's Disease Brain Pathology Exacerbated by Sleep Deprivation. Adv
Neurobiol. 2023;32:3-53. doi: 10.1007/978-3-031-32997-5_1. PMID: 37480458.

Gherman A, Dobran SA. Professor Wolfgang Grisold, President of the World
Federation of Neurology: Adapted Interview from the 12^th World
Congress for NeuroRehabilitation (WCNR) - Vienna, 2022. J Med Life. 2023
Jan;16(1):8-9. doi: 10.25122/jml-2023-1004. PMID: 36873134; PMCID: PMC9979165.

Gherman A, Dobran SA. Professor Volker Hömberg, President of the World
Federation for NeuroRehabilitation: Adapted Interview from the 12^th
World Congress for NeuroRehabilitation (WCNR) - Vienna, 2022. J Med Life. 2023
Jan;16(1):4-5. doi: 10.25122/jml-2023-1002. PMID: 36873130; PMCID: PMC9979169.

Dobran SA, Gherman A. Distinguished University Professor Vladimir Hachinski:
Adapted Interview from the 12^th World Congress for
NeuroRehabilitation (WCNR), Vienna, 2022. J Med Life. 2023 Jan;16(1):6-7. doi:
10.25122/jml-2023-1003. PMID: 36873125; PMCID: PMC9979171.

Dobran SA, Muresanu D. History of Neurotrauma: A tale from the Medieval Ages
and the Renaissance. J Med Life. 2023 Jan;16(1):1-3. doi:
10.25122/jml-2023-1001. PMID: 36873119; PMCID: PMC9979167.

Păunescu RL, Miclu Ia IV, Verişezan OR, Crecan-Suciu BD. Acute and long‑term
psychiatric symptoms associated with COVID‑19 (Review). Biomed Rep. 2022 Nov
17;18(1):4. doi: 10.3892/br.2022.1586. PMID: 36544852; PMCID: PMC9756282.

Stan A, Dragos H, Strilciuc S, Ilut S, Vacaras V, Cozma A, Panaitescu PS,
Stan H, Muresanu DF. Circadian Rhythm and Risk of Hemorrhagic Transformation
after Acute Ischemic Stroke Treated with Intravenous Thrombolysis - A Systematic
Review. CNS Neurol Disord Drug Targets. 2023;22(10):1493-1506. doi:
10.2174/1871527322666221004113752. PMID: 36200200.

Muresanu DF, Livint Popa L, Chira D, Dabala V, Hapca E, Vlad I, Vacaras V, Popescu BO, Chereches R, Strilciuc S, Brainin M. Role and Impact of Cerebrolysin for Ischemic Stroke Care. J Clin Med 2022. DOI:10.3390/jcm11051273

Benedek I, Hapca E, Vacaras V, Mureșanu D. Clinical neurology during the COVID-19 pandemic - physicians in training perspective series. J Med Life 2022. DOI:10.25122/jml-2022-1001

Popa LL, Iancu M, Livint G, Balea M, Dina C, Vacaras V, Vladescu C, Balanescu L, Buzoianu AD, Strilciuc S, Muresanu D. N-Pep-12 supplementation after ischemic stroke positively impacts frequency domain QEEG. Neurol Sci 2022. DOI:10.1007/s10072-021-05406-9

Huppertz V, Guida S, Holdoway A, Strilciuc S, Baijens L, Schols JMGA, van Helvoort A, Lansink M, Muresanu DF. Impaired Nutritional Condition After Stroke From the Hyperacute to the Chronic Phase: A Systematic Review and Meta-Analysis. Front Neurol 2022. DOI:10.3389/fneur.2021.780080

Leone MA, Mandrioli J, Russo S, Cucovici A, Gianferrari G, Lisnic V, Muresanu DF, Giuliani F, Copetti M, The Pooled Resource Open-Access Als Clinical Trials Consortium, Fontana A. Neutrophils-to-Lymphocyte Ratio Is Associated with Progression and Overall Survival in Amyotrophic Lateral Sclerosis. Biomedicines 2022. DOI:10.3390/biomedicines10020354

Davidescu EI, Odajiu I, Sandu CD, Ghergu A, Luca D, Muresanu DF, Popescu BO. Real-World Data Regarding Long-Term Administration of Natalizumab Derived from a Neurology Department along with Literature Review. CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS 2022. DOI:10.2174/1871527320666210827113733

Barac IS, Iancu M, Vacaras V, Cozma A, Negrean V, Sampelean D, Muresanu DF, Procopciuc LM. Potential Contribution of IL-27 and IL-23 Gene Polymorphisms to Multiple Sclerosis Susceptibility: An Association Analysis at Genotype and Haplotype Level. JOURNAL OF CLINICAL MEDICINE 2022. DOI:10.3390/jcm11010037

Birle C, Slavoaca D, Balea M, Livint Popa L, Muresanu I, Stefanescu E, Vacaras V, Dina C, Strilciuc S, Popescu BO, Muresanu DF. Cognitive function: holarchy or holacracy?. Neurol Sci 2021. DOI:10.1007/s10072-020-04737-3

Muresanu D. 2021: New horizons in neurorehabilitation. J Med Life 2021. DOI:10.25122/jml-2021-1004

Cretoiu D, Strilciuc S, Muresanu D. A new chapter for the Journal of Medicine and Life in 2021. J Med Life 2021. DOI:10.25122/jml-2021-1001

Muresanu D, Dobran SA, Cretoiu D. The birth of neurotrauma: a historical perspective from the Academy of Multidisciplinary Neurotraumatology (AMN). J Med Life 2021. DOI:10.25122/jml-2021-1006

Muresanu D, Strilciuc S, Buzoianu AD. Widening access in the European Union Higher Education Arena: Introducing Neurotech(EU). J Med Life 2021. DOI:10.25122/jml-2021-1002

Strilciuc S, Grad DA, Radu C, Chira D, Stan A, Ungureanu M, Gheorghe A, Muresanu FD. The economic burden of stroke: a systematic review of cost of illness studies. J Med Life 2021. DOI:10.25122/jml-2021-0361

Muresanu D, Cretoiu D. New evidence for the pharmacological intervention promoting neurorecovery after stroke: results from the joint EAN-EFNR guidelines. J Med Life 2021. DOI:10.25122/jml-2021-1003

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sahib S, Tian ZR, Bryukhovetskiy I, Manzhulo I, Menon PK, Patnaik R, Wiklund L, Sharma A. Alzheimer's disease neuropathology is exacerbated following traumatic brain injury. Neuroprotection by co-administration of nanowired mesenchymal stem cells and cerebrolysin with monoclonal antibodies to amyloid beta peptide. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.04.008

Wiklund L, Sharma A, Patnaik R, Muresanu DF, Sahib S, Tian ZR, Castellani RJ, Nozari A, Lafuente JV, Sharma HS. Upregulation of hemeoxygenase enzymes HO-1 and HO-2 following ischemia-reperfusion injury in connection with experimental cardiac arrest and cardiopulmonary resuscitation: Neuroprotective effects of methylene blue. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.009

Sharma HS, Lafuente JV, Feng L, Muresanu DF, Menon PK, Castellani RJ, Nozari A, Sahib S, Tian ZR, Buzoianu AD, Sjöquist PO, Patnaik R, Wiklund L, Sharma A. Methamphetamine exacerbates pathophysiology of traumatic brain injury at high altitude. Neuroprotective effects of nanodelivery of a potent antioxidant compound H-290/51. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.008

Sharma A, Muresanu DF, Patnaik R, Menon PK, Tian ZR, Sahib S, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Skaper SD, Bryukhovetskiy I, Manzhulo I, Wiklund L, Sharma HS. Histamine H3 and H4 receptors modulate Parkinson's disease induced brain pathology. Neuroprotective effects of nanowired BF-2649 and clobenpropit with anti-histamine-antibody therapy. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.003

Muresanu D, Popescu B, Strilciuc S, Radu C, Tiu C. Academia steps up to strengthen health policymaking in Romania: a roadmap for tackling difficulties encountered by Ministry of Health specialty commissions. J Med Life 2021. DOI:10.25122/jml-2021-1005

Balea M, Birle C, Costin C, Marton J, Muresanu IA, Jemna N, Popa LL, Slavoaca D, Rosu OV, Stan A, Vacaras V, Strilciuc S, Muresanu DF. Effects of N-Pep-12 dietary supplementation on neurorecovery after ischemic stroke. Neurol Sci 2021. DOI:10.1007/s10072-020-04707-9

Livint Popa L, Dragos HM, Strilciuc S, Pantelemon C, Muresanu I, Dina C, Vacaras V, Muresanu D. Added Value of QEEG for the Differential Diagnosis of Common Forms of Dementia. Clin EEG Neurosci 2021. DOI:10.1177/1550059420971122

Niu F, Sharma A, Wang Z, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Menon PK, Patnaik R, Wiklund L, Sharma HS. Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.004

Strilciuc S, Grad DA, Mixich V, Stan A, Buzoianu AD, Vladescu C, Vintan MA. Societal Cost of Ischemic Stroke in Romania: Results from a Retrospective County-Level Study. Brain Sci 2021. DOI:10.3390/brainsci11060689

Vester JC, Buzoianu AD, Florian SI, Hömberg V, Kim SH, Lee TMC, Matula C, Poon WS, Sandesc D, von Steinbüchel N, Strilciuc S, Vos PE, von Wild K, Muresanu D. Cerebrolysin after moderate to severe traumatic brain injury: prospective meta-analysis of the CAPTAIN trial series. Neurol Sci 2021. DOI:10.1007/s10072-020-04974-6

Sahib S, Sharma A, Muresanu DF, Zhang Z, Li C, Tian ZR, Buzoianu AD, Lafuente JV, Castellani RJ, Nozari A, Patnaik R, Menon PK, Wiklund L, Sharma HS. Nanodelivery of traditional Chinese Gingko Biloba extract EGb-761 and bilobalide BN-52021 induces superior neuroprotective effects on pathophysiology of heat stroke. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.007

Sharma A, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Wiklund L, Sharma HS. Manganese nanoparticles induce blood-brain barrier disruption, cerebral blood flow reduction, edema formation and brain pathology associated with cognitive and motor dysfunctions. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.015

Cucovici A, Fontana A, Ivashynka A, Russo S, Renna V, Mazzini L, Gagliardi I, Mandrioli J, Martinelli I, Lisnic V, Muresanu DF, Zarrelli M, Copetti M, Leone MA. The Impact of Lifetime Alcohol and Cigarette Smoking Loads on Amyotrophic Lateral Sclerosis Progression: A Cross-Sectional Study. Life (Basel) 2021. DOI:10.3390/life11040352

Sharma HS, Muresanu DF, Ozkizilcik A, Sahib S, Tian ZR, Lafuente JV, Castellani RJ, Nozari A, Feng L, Buzoianu AD, Menon PK, Patnaik R, Wiklund L, Sharma A. Superior antioxidant and anti-ischemic neuroprotective effects of cerebrolysin in heat stroke following intoxication of engineered metal Ag and Cu nanoparticles: A comparative biochemical and physiological study with other stroke therapies. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.014

Sharma HS, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Li C, Zhang Z, Wiklund L, Sharma A. Cerebrolysin restores balance between excitatory and inhibitory amino acids in brain following concussive head injury. Superior neuroprotective effects of TiO(2) nanowired drug delivery. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.016

Sharma A, Feng L, Muresanu DF, Huang H, Menon PK, Sahib S, Ryan Tian Z, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Wiklund L, Sharma HS. Topical application of CNTF, GDNF and BDNF in combination attenuates blood-spinal cord barrier permeability, edema formation, hemeoxygenase-2 upregulation, and cord pathology. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.013

Sharma HS, Lafuente JV, Muresanu DF, Sahib S, Tian ZR, Menon PK, Castellani RJ, Nozari A, Buzoianu AD, Sjöquist PO, Patnaik R, Wiklund L, Sharma A. Neuroprotective effects of insulin like growth factor-1 on engineered metal nanoparticles Ag, Cu and Al induced blood-brain barrier breakdown, edema formation, oxidative stress, upregulation of neuronal nitric oxide synthase and brain pathology. Prog Brain Res 2021. DOI:10.1016/bs.pbr.2021.06.005

Beghi E, Binder H, Birle C, Bornstein N, Diserens K, Groppa S, Homberg V, Lisnic V, Pugliatti M, Randall G, Saltuari L, Strilciuc S, Vester J, Muresanu D. European Academy of Neurology and European Federation of Neurorehabilitation Societies guideline on pharmacological support in early motor rehabilitation after acute ischaemic stroke. Eur J Neurol 2021. DOI:10.1111/ene.14936

D'Inverno GA, Brunetti S, Sampoli ML, Muresanu DF, Rufa A, Bianchini M. Visual Sequential Search Test Analysis: An Algorithmic Approach. MATHEMATICS 2021. DOI:10.3390/math9222952

Vacaras V, Maior T, Muntiu A, Talos A, Muresanu DF. Foramen Magnum Meningioma - A common histological tumor in a rare location. BALNEO AND PRM RESEARCH JOURNAL 2021. DOI:10.12680/balneo.2021.450

Stanca DM, Seres DL, Rusca M, Achim A, Muresanu DF. Community-acquired Klebsiella pneumoniae systemic infection complicated with rhombencephalitis. CLINICAL CASE REPORTS 2021. DOI:10.1002/ccr3.3666

Cucovici A, Ivashynka A, Fontana A, Russo S, Mazzini L, Mandrioli J, Lisnic V, Muresanu DF, Leone MA. Coffee and Tea Consumption Impact on Amyotrophic Lateral Sclerosis Progression: A Multicenter Cross-Sectional Study. FRONTIERS IN NEUROLOGY 2021. DOI:10.3389/fneur.2021.637939

Davidescu EI, Odajiu I, Tulba D, Sandu CD, Bunea T, Sandu G, Muresanu DF, Balanescu P, Popescu BO. Prognostic Factors in COVID-19 Patients With New Neurological Manifestations: A Retrospective Cohort Study in a Romanian Neurology Department. FRONTIERS IN AGING NEUROSCIENCE 2021. DOI:10.3389/fnagi.2021.645611

Vacaras V, Hapca E, Draghici NC, Muresanu DF. Severe cervical compressive polydiscopathic myelopathy with features of motor neuron disease: A case report. CLINICAL CASE REPORTS 2021. DOI:10.1002/ccr3.3740

Barac IS, Vacaras V, Cozma A, Valeanu M, Decea N, Muresanu DF, Procopciuc LM. IL27 T4730C Polymorphism and Serology in Multiple Sclerosis: A Pilot Study. IN VIVO 2021. DOI:10.21873/invivo.12572

Alvarez XA, Alvarez I, Martinez A, Romero I, Benito C, Suarez I, Mourente S, Fantini M, Figueroa J, Aleixandre M, Linares C, Muresanu D, Winter S, Moessler H. Serum VEGF Predicts Clinical Improvement Induced by Cerebrolysin plus Donepezil in Patients with Advanced Alzheimer's Disease. International Journal of Neuropsychopharmacology 2021. DOI:10.1093/ijnp/pyaa046

Tatomir A, Beltrand A, Nguyen V, Courneya J-P, Boodhoo D, Cudrici C, Muresanu DF, Rus V, Badea TC, Rus H. RGC-32 Acts as a Hub to Regulate the Transcriptomic Changes Associated With Astrocyte Development and Reactive Astrocytosis. Frontiers in Immunology 2021. DOI:10.3389/fimmu.2021.705308

Stanciu T-V, Nemes B, Mariesan D, Vacaras V, Muresanu DF. Young patient`s secondary prevention in ischemic stroke with the percutaneous closure of the patent foramen ovale and postoperative repermeabilisation – case report. Romanian Journal of Neurology/ Revista Romana de Neurologie 2021. DOI:10.37897/RJN.2021.1.15

Vacaraș V, Radu RM, Cucu E, Muresanu FD. Multiple strokes and cerebral microangiopathy in a patient with Churg-Strauss syndrome. Medicine and Pharmacy Reports 2021. DOI:10.15386/mpr-1587

Slavoaca D, Muresanu D, Birle C, Rosu OV, Chirila I, Dobra I, Jemna N, Strilciuc S, Vos P. Biomarkers in traumatic brain injury: new concepts. Neurol Sci 2020. DOI:10.1007/s10072-019-04238-y

Livint Popa L, Dragos H, Pantelemon C, Verisezan Rosu O, Strilciuc S. The Role of Quantitative EEG in the Diagnosis of Neuropsychiatric Disorders. J Med Life 2020. DOI:10.25122/jml-2019-0085

Sharma HS, Sahib S, Tian ZR, Muresanu DF, Nozari A, Castellani RJ, Lafuente JV, Wiklund L, Sharma A. Protein kinase inhibitors in traumatic brain injury and repair: New roles of nanomedicine. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.009

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Tian ZR, Sahib S, Bryukhovetskiy I, Bryukhovetskiy A, Buzoianu AD, Patnaik R, Wiklund L, Sharma A. Pathophysiology of blood-brain barrier in brain tumor. Novel therapeutic advances using nanomedicine. Int Rev Neurobiol 2020. DOI:10.1016/bs.irn.2020.03.001

Muresanu DF, Sharma A, Sahib S, Tian ZR, Feng L, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Sjöquist PO, Patnaik R, Wiklund L, Sharma HS. Diabetes exacerbates brain pathology following a focal blast brain injury: New role of a multimodal drug cerebrolysin and nanomedicine. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.004

Sharma A, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Sahib S, Tian ZR, Buzoianu AD, Patnaik R, Wiklund L, Sharma HS. Mild traumatic brain injury exacerbates Parkinson's disease induced hemeoxygenase-2 expression and brain pathology: Neuroprotective effects of co-administration of TiO(2) nanowired mesenchymal stem cells and cerebrolysin. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.010

Draghici NC, Tamas MM, Leucuta DC, Lupescu TD, Strilciuc S, Rednic S, Muresanu DF. Diagnosis Accuracy of Carpal Tunnel Syndrome in Diabetic Neuropathy. Medicina (Kaunas) 2020. DOI:10.3390/medicina56060279

Pantelemon C, Necula V, Berghe AS, Livint-Popa L, Palade S, Vacaras V, Muresanu IA, Strilciuc S, Muresanu FD. Neurodevelopmental Aspects and Cortical Auditory Maturation in Children with Cochlear Implants. Medicina (Kaunas) 2020. DOI:10.3390/medicina56070344

Oancea M, Ciortea R, Diculescu D, Poienar AA, Grigore M, Lupean RA, Nicula R, Chira D, Strilciuc S, Mihu D. Spontaneous Heterotopic Pregnancy with Unaffected Intrauterine Pregnancy: Systematic Review of Clinical Outcomes. Medicina (Kaunas) 2020. DOI:10.3390/medicina56120665

Deac S, Stana MM, Havasi AD, Cainap C, Popita AR, Bordeianu AM, Cainap S, Bota M, Bochis OV. Paraneoplastic cerebellar degeneration associated with anti-Yo antibodies in an ovarian cancer case: A case report. Gynecol Oncol Rep 2020. DOI:10.1016/j.gore.2020.100695

Oancea M, Grigore M, Ciortea R, Diculescu D, Bodean D, Bucuri C, Strilciuc S, Rada M, Mihu D. Uterine Artery Doppler Ultrasonography for First Trimester Prediction of Preeclampsia in Individuals at Risk from Low-Resource Settings. Medicina (Kaunas) 2020. DOI:10.3390/medicina56090428

Niu F, Sharma A, Wang Z, Feng L, Muresanu DF, Sahib S, Tian ZR, Lafuente JV, Buzoianu AD, Castellani RJ, Nozari A, Patnaik R, Wiklund L, Sharma HS. Co-administration of TiO(2)-nanowired dl-3-n-butylphthalide (dl-NBP) and mesenchymal stem cells enhanced neuroprotection in Parkinson's disease exacerbated by concussive head injury. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.011

Hilz MJ, Wang R, Liu M, Muresanu D, Flanagan S, Winder K, Hösl K, Hummel T. Emotional and Autonomic Processing of Olfactory Stimuli Is Compromised in Patients with a History of Mild Traumatic Brain Injury. J Neurotrauma 2020. DOI:10.1089/neu.2018.6215

Muntean MV, Strilciuc S, Muntean V. Reply to letter to the editor regarding article "Flap warming improves intraoperative indocyanine green angiography (ICGA) assessment of perfusion. An experimental study" by Muntean et al. J Plast Reconstr Aesthet Surg 2020. DOI:10.1016/j.bjps.2019.11.054

Slavoaca D, Birle C, Stan A, Tatomir A, Popa O, Rosu P, Vulcan AM, Chira D, Livint Popa L, Dina C, Vacaras V, Strilciuc S, Vos P. Prediction of Neurocognitive Outcome after Moderate-Severe Traumatic Brain Injury Using Serum Neuron-Specific Enolase and S100 biomarkers. J Med Life 2020. DOI:10.25122/jml-2020-0147

Sharma A, Muresanu DF, Sahib S, Tian ZR, Castellani RJ, Nozari A, Lafuente JV, Buzoianu AD, Bryukhovetskiy I, Manzhulo I, Patnaik R, Wiklund L, Sharma HS. Concussive head injury exacerbates neuropathology of sleep deprivation: Superior neuroprotection by co-administration of TiO(2)-nanowired cerebrolysin, alpha-melanocyte-stimulating hormone, and mesenchymal stem cells. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.003

Sahib S, Sharma A, Menon PK, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Bryukhovetskiy I, Tian ZR, Patnaik R, Buzoianu AD, Wiklund L, Sharma HS. Cerebrolysin enhances spinal cord conduction and reduces blood-spinal cord barrier breakdown, edema formation, immediate early gene expression and cord pathology after injury. Prog Brain Res 2020. DOI:10.1016/bs.pbr.2020.09.012

Poon W, Matula C, Vos PE, Muresanu DF, von Steinbüchel N, von Wild K, Hömberg V, Wang E, Lee TMC, Strilciuc S, Vester JC. Correction to: Safety and efficacy of Cerebrolysin in acute brain injury and neurorecovery: CAPTAIN I-a randomized, placebo-controlled, double-blind, Asian-Pacific trial. Neurol Sci 2020. DOI:10.1007/s10072-019-04149-y

Birle C, Slavoaca D, Muresanu I, Chira D, Vacaras V, Stan AD, Dina C, Strilciuc S. The Effect of Cerebrolysin on the Predictive Value of Baseline Prognostic Risk Score in Moderate and Severe Traumatic Brain Injury. J Med Life 2020. DOI:10.25122/jml-2020-0146

Pantelemon C, Necula V, Livint Popa L, Palade S, Strilciuc S, Muresanu DF. Assessment of Cortical Auditory Function Using Electrophysiological and Neuropsychological Measurements in Children with Bone-Anchored Hearing Aids. J Med Life 2020. DOI:10.25122/jml-2019-0097

Vacaras V, Cordos AM, Rahovan I, Frunze S, Muresanu DF. Binswanger's disease: Case presentation and differential diagnosis. CLINICAL CASE REPORTS 2020. DOI:10.1002/ccr3.3459

Vacaras V, Cucu EE, Radu R, Muresanu DF. Paraneoplastic Stiff Person Syndrome in Early-Stage Breast Cancer with Positive Anti-Amphiphysin Antibodies. CASE REPORTS IN NEUROLOGY 2020. DOI:10.1159/000508942

Tatomir A, Beltrand A, Nguyen V, Boodhoo D, Mekala A, Cudrici C, Badea TC, Muresanu DF, Rus V, Rus H. RGC-32 Regulates Generation of Reactive Astrocytes in Experimental Autoimmune Encephalomyelitis. Frontiers in Immunology 2020. DOI:10.3389/fimmu.2020.608294

Stan A, Gherghel N, Muresanu DF. Adult-onset idiopathic lower-extremity dystonia: A rare task-specific dystonia. Clinical Neurology and Neurosurgery 2020. DOI:10.1016/j.clineuro.2020.106106

Muresanu D, Buzoianu AD. Moving Forward with Medical Education in Times of a Pandemic: Universities in Romania Double Down on Virtual and Blended Learning. Journal of medicine and life 2020. DOI:10.25122/jml-2020-1008

Muresanu D, Strilciuc S. The Silver Lining in a Time of Crisis: The Foundation of the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) Conference Proceedings Go Virtual. Journal of medicine and life 2020. DOI:10.25122/jml-2020-1006

Moro E, Deuschl G, de Visser M, Muresanu D, Soffietti R, Marson A, Vidailhet M, Vodusek DB, Bassetti CLA. A call from the European Academy of Neurology on COVID-19. The Lancet Neurology 2020. DOI:10.1016/S1474-4422(20)30151-4

Ozkizilcik A, Sharma A, Lafuente JV, Muresanu DF, Castellani RJ, Nozari A, Tian ZR, Mössler H, Sharma HS. Nanodelivery of cerebrolysin reduces pathophysiology of Parkinson's disease. Prog Brain Res 2019. DOI:10.1016/bs.pbr.2019.03.014

Muresanu DF, Strilciuc S, Stan A. Current Drug Treatment of Acute Ischemic Stroke: Challenges and Opportunities. CNS Drugs 2019. DOI:10.1007/s40263-019-00663-x

Niu F, Sharma A, Feng L, Ozkizilcik A, Muresanu DF, Lafuente JV, Tian ZR, Nozari A, Sharma HS. Nanowired delivery of DL-3-n-butylphthalide induces superior neuroprotection in concussive head injury. Prog Brain Res 2019. DOI:10.1016/bs.pbr.2019.03.008

Sharma HS, Muresanu DF, Castellani RJ, Nozari A, Lafuente JV, Tian ZR, Ozkizilcik A, Manzhulo I, Mössler H, Sharma A. Nanowired delivery of cerebrolysin with neprilysin and p-Tau antibodies induces superior neuroprotection in Alzheimer's disease. Prog Brain Res 2019. DOI:10.1016/bs.pbr.2019.03.009

Sharma A, Muresanu DF, Ozkizilcik A, Tian ZR, Lafuente JV, Manzhulo I, Mössler H, Sharma HS. Sleep deprivation exacerbates concussive head injury induced brain pathology: Neuroprotective effects of nanowired delivery of cerebrolysin with α-melanocyte-stimulating hormone. Prog Brain Res 2019. DOI:10.1016/bs.pbr.2019.03.002

Muntean MV, Ardelean F, Strilciuc S, Pestean C, Georgescu AV, Muntean V. Flap warming improves intraoperative indocyanine green angiography (ICGA) assessment of perfusion. An experimental study. J Plast Reconstr Aesthet Surg 2019. DOI:10.1016/j.bjps.2019.03.014

Sharma A, Castellani RJ, Smith MA, Muresanu DF, Dey PK, Sharma HS. 5-Hydroxytryptophan: A precursor of serotonin influences regional blood-brain barrier breakdown, cerebral blood flow, brain edema formation, and neuropathology. Int Rev Neurobiol 2019. DOI:10.1016/bs.irn.2019.06.005

Sharma HS, Feng L, Muresanu DF, Castellani RJ, Sharma A. Neuroprotective effects of a potent bradykinin B2 receptor antagonist HOE-140 on microvascular permeability, blood flow disturbances, edema formation, cell injury and nitric oxide synthase upregulation following trauma to the spinal cord. Int Rev Neurobiol 2019. DOI:10.1016/bs.irn.2019.06.008

Muresanu DF, Sharma A, Patnaik R, Menon PK, Mössler H, Sharma HS. Exacerbation of blood-brain barrier breakdown, edema formation, nitric oxide synthase upregulation and brain pathology after heat stroke in diabetic and hypertensive rats. Potential neuroprotection with cerebrolysin treatment. Int Rev Neurobiol 2019. DOI:10.1016/bs.irn.2019.06.007

Sahib S, Niu F, Sharma A, Feng L, Tian ZR, Muresanu DF, Nozari A, Sharma HS. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation. Int Rev Neurobiol 2019. DOI:10.1016/bs.irn.2019.06.009

Sharma HS, Muresanu DF, Nozari A, Castellani RJ, Dey PK, Wiklund L, Sharma A. Anesthetics influence concussive head injury induced blood-brain barrier breakdown, brain edema formation, cerebral blood flow, serotonin levels, brain pathology and functional outcome. Int Rev Neurobiol 2019. DOI:10.1016/bs.irn.2019.06.006

Pantelemon C, Necula V, Livint Popa L, Palade S, Strilciuc S, Muresanu DF. The Potential Use of P1 CAEP as a Biomarker for Assessing Central Auditory Pathway Maturation in Hearing loss and Associated Disabilities: a case report. J Med Life 2019. DOI:10.25122/jml-2019-0096

von Wild T, Brunelli GA, von Wild KRH, Löhnhardt M, Catoi C, Catoi AF, Vester JC, Strilciuc S, Trillenberg P. Regeneration of Denervated Skeletal Muscles - Brunelli's CNS-PNS Paradigm. Journal of medicine and life 2019. DOI:10.25122/jml-2019-0063

Mènon CS, Ahami AOT, Latifi M, Mureşanu DF, Gam I, Obayagbona VO. S(troke impact)moroccan(on the cognitive) functions of(neuro)-(lesioned)in the gharb region(patients). Acta Neuropsychologica 2019. DOI:10.5604/01.3001.0013.0823

Sahib S, Niu F, Sharma A, Feng L, Tian ZR, Muresanu DF, Nozari A, Sharma HS. Potentiation of spinal cord conduction and neuroprotection following nanodelivery of DL-3-n-butylphthalide in titanium implanted nanomaterial in a focal spinal cord injury induced functional outcome, blood-spinal cord barrier breakdown and edema formation. International Review of Neurobiology 2019. DOI:10.1016/bs.irn.2019.06.009

Balea M, Muresanu D, Alvarez A, Homberg V, Bajenaru O, Guekht A, Heiss WD, Popa L, Vester J, Muresanu I, Birle C, Slavoaca D. VaD - An Integrated Framework for Cognitive Rehabilitation. CNS Neurol Disord Drug Targets 2018. DOI:10.2174/1871527317666180219164545

Ozkizilcik A, Williams R, Tian ZR, Muresanu DF, Sharma A, Sharma HS. Synthesis of Biocompatible Titanate Nanofibers for Effective Delivery of Neuroprotective Agents. Methods Mol Biol 2018. DOI:10.1007/978-1-4939-7571-6_35

Catalin B, Rogoveanu OC, Pirici I, Balseanu TA, Stan A, Tudorica V, Balea M, Mindrila I, Albu CV, Mohamed G, Pirici D, Muresanu DF. Cerebrolysin and Aquaporin 4 Inhibition Improve Pathological and Motor Recovery after Ischemic Stroke. CNS Neurol Disord Drug Targets 2018. DOI:10.2174/1871527317666180425124340

Alvarez XA, Alvarez I, Aleixandre M, Linares C, Muresanu D, Winter S, Moessler H. Severity-Related Increase and Cognitive Correlates of Serum VEGF Levels in Alzheimer's Disease ApoE4 Carriers. J Alzheimers Dis 2018. DOI:10.3233/JAD-160477

Lafuente JV, Sharma A, Muresanu DF, Ozkizilcik A, Tian ZR, Patnaik R, Sharma HS. Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron. Mol Neurobiol 2018. DOI:10.1007/s12035-017-0744-7

Toader LE, Rosu GC, Catalin B, Tudorica V, Pirici I, Taisescu O, Muresanu DF. Clinical and Histopathological Assessment on an Animal Model with Experimental Autoimmune Encephalomyelitis. Curr Health Sci J 2018. DOI:10.12865/CHSJ.44.03.12

Bornstein NM, Guekht A, Vester J, Heiss WD, Gusev E, Hömberg V, Rahlfs VW, Bajenaru O, Popescu BO, Muresanu D. Safety and efficacy of Cerebrolysin in early post-stroke recovery: a meta-analysis of nine randomized clinical trials. Neurol Sci 2018. DOI:10.1007/s10072-017-3214-0

Ozkizilcik A, Sharma A, Muresanu DF, Lafuente JV, Tian ZR, Patnaik R, Mössler H, Sharma HS. Timed Release of Cerebrolysin Using Drug-Loaded Titanate Nanospheres Reduces Brain Pathology and Improves Behavioral Functions in Parkinson's Disease. Molecular Neurobiology 2018. DOI:10.1007/s12035-017-0747-4

Wang R, Hösl KM, Ammon F, Markus J, Koehn J, Roy S, Liu M, de Rojas Leal C, Muresanu D, Flanagan SR, Hilz MJ. Eyeball pressure stimulation induces subtle sympathetic activation in patients with a history of moderate or severe traumatic brain injury. Clin Neurophysiol 2018. DOI:10.1016/j.clinph.2018.03.011

Feng L, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, Ozkizilcik A, Tian ZR, Sharma HS. TiO(2)-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury. Molecular Neurobiology 2018. DOI:10.1007/s12035-017-0746-5

Sharma A, Muresanu DF, Lafuente JV, Sjöquist PO, Patnaik R, Ryan Tian Z, Ozkizilcik A, Sharma HS. Cold Environment Exacerbates Brain Pathology and Oxidative Stress Following Traumatic Brain Injuries: Potential Therapeutic Effects of Nanowired Antioxidant Compound H-290/51. Molecular Neurobiology 2018. DOI:10.1007/s12035-017-0740-y

Patnaik R, Sharma A, Skaper SD, Muresanu DF, Lafuente JV, Castellani RJ, Nozari A, Sharma HS. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer's Disease. Mol Neurobiol 2018. DOI:10.1007/s12035-017-0743-8

Feng LY, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, Ozkizilcik A, Tian ZR, Sharma HS. TiO2-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury. MOLECULAR NEUROBIOLOGY 2018. DOI:10.1007/s12035-017-0746-5

Toader LE, Rosu GC, Catalin B, Pirici I, Gilceava IC, Albu VC, Istrate-Ofiteru AM, Muresanu DF, Pirici D. Cerebrolysin increases motor recovery and decreases inflammation in a mouse model of autoimmune encephalitis. ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY 2018. 

Huang H, Sharma HS, Chen L, Otom A, Al Zoubi ZM, Saberi H, Muresanu DF, He X. Review of clinical neurorestorative strategies for spinal cord injury: Exploring history and latest progresses. Journal of Neurorestoratology 2018. DOI:10.26599/JNR.2018.9040013

Huang H, Young W, Chen L, Feng S, Zoubi ZMA, Sharma HS, Saberi H, Moviglia GA, He X, Muresanu DF, Sharma A, Otom A, Andrews RJ, Al-Zoubi A, Bryukhovetskiy AS, Chernykh ER, Domańska-Janik K, Jafar E, Johnson WE, Li Y, Li D, Luan Z, Mao G, Shetty AK, Siniscalco D, Skaper S, Sun T, Wang Y, Wiklund L, Xue Q, You S-W, Zheng Z, Dimitrijevic MR, Masri WSE, Sanberg PR, Xu Q, Luan G, Chopp M, Cho K-S, Zhou X-F, Wu P, Liu K, Mobasheri H, Ohtori S, Tanaka H, Han F, Feng Y, Zhang S, Lu Y, Zhang Z, Rao Y, Tang Z, Xi H, Wu L, Shen S, Xue M, Xiang G, Guo X, Yang X, Hao Y, Hu Y, Li J, Ao Q, Wang B, Zhang Z, Lu M, Li T. Clinical Cell Therapy Guidelines for Neurorestoration (IANR/CANR 2017). Cell Transplantation 2018. DOI:10.1177/0963689717746999

Pirici I, Balsanu TA, Bogdan C, Margaritescu C, Divan T, Vitalie V, Mogoanta L, Pirici D, Carare RO, Muresanu DF. Inhibition of aquaporin-4 improves the outcome of ischaemic stroke and modulates brain paravascular drainage pathways. International Journal of Molecular Sciences 2018. DOI:10.3390/ijms19010046

Sharma HS, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma A. Co-administration of TiO2 nanowired mesenchymal stem cells with cerebrolysin potentiates neprilysin level and reduces brain pathology in alzheimer’s disease. Molecular Neurobiology 2018. DOI:10.1007/s12035-017-0742-9

Liu M, Roy S, Wang R, Hösl K, Muresanu DF, Hilz MJ. Patients with a history of mild traumatic brain injury have impaired autonomic responses to happy and fearful music. Clinical Autonomic Research 2018. 

Sharma A, Menon PK, Patnaik R, Muresanu DF, Lafuente JV, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma HS. Novel Treatment Strategies Using TiO(2)-Nanowired Delivery of Histaminergic Drugs and Antibodies to Tau With Cerebrolysin for Superior Neuroprotection in the Pathophysiology of Alzheimer's Disease. International Review of Neurobiology 2017. DOI:10.1016/bs.irn.2017.09.002

Guekht A, Vester J, Heiss WD, Gusev E, Hoemberg V, Rahlfs VW, Bajenaru O, Popescu BO, Doppler E, Winter S, Moessler H, Muresanu D. Safety and efficacy of Cerebrolysin in motor function recovery after stroke: a meta-analysis of the CARS trials. Neurological Sciences 2017. DOI:10.1007/s10072-017-3037-z

Stan A, Birle C, Blesneag A, Iancu M. Cerebrolysin and early neurorehabilitation in patients with acute ischemic stroke: a prospective, randomized, placebo-controlled clinical study. J Med Life 2017. 

Sharma HS, Patnaik R, Muresanu DF, Lafuente JV, Ozkizilcik A, Tian ZR, Nozari A, Sharma A. Histaminergic Receptors Modulate Spinal Cord Injury-Induced Neuronal Nitric Oxide Synthase Upregulation and Cord Pathology: New Roles of Nanowired Drug Delivery for Neuroprotection. International Review of Neurobiology 2017. DOI:10.1016/bs.irn.2017.09.001

Gharagozli K, Harandi AA, Houshmand S, Akbari N, Muresanu DF, Vester J, Winter S, Moessler H. Efficacy and safety of Cerebrolysin treatment in early recovery after acute ischemic stroke: a randomized, placebo-controlled, double-blinded, multicenter clinical trial. J Med Life 2017. 

Sharma HS, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A, Moessler H, Sharma A. Nanowired delivery of cerebrolysin and mesenchymal stem cells potentiate neuroprotection following concussive head injury. Journal of Head Trauma Rehabilitation 2017. 

Sharma A, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A, Moessler H, Sharma HS. Spinal cord injury at hot environment exacerbates blood-spinal cord barrier disruption, edema formation and cellular damages. Effective treatment with a multimodal drug cerebrolsyin. Journal of Head Trauma Rehabilitation 2017. 

Muresanu DF, Sharma HS, Lafuente JV, Nozari A, Patnaik R, Tian ZR, Ozkizilcik A, Moessler H, Sharma A. Hypertension associated with silica dust intoxication aggravates brain pathology following traumatic brain injury: New roles of neurotrophic factors. Journal of Head Trauma Rehabilitation 2017. 

Patnaik R, Sharma A, Skaper SD, Muresanu DF, Lafuente JV, Castellani RJ, Nozari A, Sharma HS. Histamine H3 Inverse Agonist BF 2649 or Antagonist with Partial H4 Agonist Activity Clobenpropit Reduces Amyloid Beta Peptide-Induced Brain Pathology in Alzheimer’s Disease. Molecular Neurobiology 2017. DOI:10.1007/s12035-017-0743-8

Lafuente JV, Sharma A, Muresanu DF, Ozkizilcik A, Tian ZR, Patnaik R, Sharma HS. Repeated Forced Swim Exacerbates Methamphetamine-Induced Neurotoxicity: Neuroprotective Effects of Nanowired Delivery of 5-HT3-Receptor Antagonist Ondansetron. Molecular Neurobiology 2017. DOI:10.1007/s12035-017-0744-7

Sharma A, Muresanu DF, Lafuente JV, Sjöquist P-O, Patnaik R, Ryan Tian Z, Ozkizilcik A, Sharma HS. Cold Environment Exacerbates Brain Pathology and Oxidative Stress Following Traumatic Brain Injuries: Potential Therapeutic Effects of Nanowired Antioxidant Compound H-290/51. Molecular Neurobiology 2017. DOI:10.1007/s12035-017-0740-y

Feng L, Sharma A, Niu F, Huang Y, Lafuente JV, Muresanu DF, Ozkizilcik A, Tian ZR, Sharma HS. TiO(2)-Nanowired Delivery of DL-3-n-butylphthalide (DL-NBP) Attenuates Blood-Brain Barrier Disruption, Brain Edema Formation, and Neuronal Damages Following Concussive Head Injury. Molecular Neurobiology 2017. DOI:10.1007/s12035-017-0746-5

Sharma HS, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Ozkizilcik A, Castellani RJ, Mössler H, Sharma A. Co-Administration of TiO2 Nanowired Mesenchymal Stem Cells with Cerebrolysin Potentiates Neprilysin Level and Reduces Brain Pathology in Alzheimer’s Disease. Molecular Neurobiology 2017. DOI:10.1007/s12035-017-0742-9

Sharma A, Muresanu D, Nozari A, Lafuente JV, Tian R, Ozkizilcik A, Sharma HS. Concussive head injury exacerbates sleep deprivation-induced brain pathology. Coadministration of nanowired antioxidant H-290/51 and serotonin 5-HT6 receptor antagonist SB-399885. Brain Injury 2017. 

Muresanu D, Sharma HS, Nozari A, Lafuente JV, Tian R, Ozkizilcik A, Sharma A. Traumatic brain injury in diabetic and hypertensive rats exacerbates brain pathology and functional outcome-role of neurotrophic factors and nanomedicine. Brain Injury 2017. 

Sharma HS, Muresanu D, Lafuente JV, Nozari A, Tian R, Ozkizilcik A, Sharma A. Mild traumatic brain injury exacerbates Alzheimer's disease brain pathology: Neuroprotective effects of nanowired mesenchymal cells and cerebrolysin. Brain Injury 2017. 

Menon PK, Sharma A, Lafuente JV, Muresanu DF, Aguilar ZP, Wang YA, Patnaik R, Mössler H, Sharma HS. Intravenous Administration of Functionalized Magnetic Iron Oxide Nanoparticles Does Not Induce CNS Injury in the Rat: Influence of Spinal Cord Trauma and Cerebrolysin Treatment. International Review of Neurobiology 2017. 

Stanca DM, Paraschiv A, Achim A, Barta A, Mureşanu D. Concomitant acute stroke and acute myocardial infarction-case report. Clujul Medical 2017. 

Selejan O, Muresanu DF, Popa L, Muresanu-Oloeriu I, Iudean D, Buzoianu A, Suciu S. Credibility judgments in web page design - a brief review. J Med Life 2016.

Balta F, Merticariu M, Taban C, Neculau G, Merticariu A, Muresanu D, Badescu D, Jinga V. The remote effects of intravitreal anti-VEGF therapy. J Med Life 2016.

Muresanu DF, Heiss WD, Hoemberg V, Bajenaru O, Popescu CD, Vester JC, Rahlfs VW, Doppler E, Meier D, Moessler H, Guekht A. Cerebrolysin and Recovery After Stroke (CARS): A Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial. Stroke 2016. DOI:10.1161/STROKEAHA.115.009416

Albu S, Nagy A, Doros C, Marceanu L, Cozma S, Musat G, Trabalzini F. Treatment of Meniere's disease with intratympanic dexamethazone plus high dosage of betahistine. Am J Otolaryngol 2016. DOI:10.1016/j.amjoto.2015.12.007

Sharma HS, Muresanu DF, Sharma A. Alzheimer's disease: Cerebrolysin and nanotechnology as a therapeutic strategy. Neurodegenerative Disease Management 2016. DOI:10.2217/nmt-2016-0037

Sharma HS, Muresanu DF, Lafuente JV, Nozari A, Patnaik R, Skaper SD, Sharma A. Pathophysiology of blood-brain barrier in brain injury in cold and hot environments: Novel drug targets for neuroprotection. CNS and Neurological Disorders - Drug Targets 2016. DOI:10.2174/1871527315666160902145145

Gadhave K, Bolshette N, Ahire A, Pardeshi R, Thakur K, Trandafir C, Istrate A, Ahmed S, Lahkar M, Muresanu DF, Balea M. The ubiquitin proteasomal system: a potential target for the management of Alzheimer's disease. Journal of Cellular and Molecular Medicine 2016. DOI:10.1111/jcmm.12817

Sharma A, Menon P, Muresanu DF, Ozkizilcik A, Tian ZR, Lafuente JV, Sharma HS. Nanowired Drug Delivery Across the Blood-Brain Barrier in Central Nervous System Injury and Repair. CNS and Neurological Disorders - Drug Targets 2016. DOI:10.2174/1871527315666160819123059

Alvarez XA, Alvarez I, Iglesias O, Crespo I, Figueroa J, Aleixandre M, Linares C, Granizo E, Garcia-Fantini M, Marey J, Masliah E, Winter S, Muresanu D, Moessler H. Synergistic increase of serum BDNF in Alzheimer patients treated with cerebrolysin and donepezil: Association with cognitive improvement in apoe4 cases. International Journal of Neuropsychopharmacology 2016. DOI:10.1093/ijnp/pyw024

Sharma H, Muresanu D, Lafuente J, Patnaik R, Moessler H, Tian ZR, Sharma A. Nanodrug delivery of a multimodal novel drug cerebrolysin reduces engineered nanoparticles induced aggravation of heat stroke induced ubiquitin expression and brain pathology. Brain Injury 2016. 

Sharma A, Muresanu D, Lafuente JV, Patnaik R, Tian ZR, Moessler H, Sharma HS. Cold environment exacerbates brain pathology and oxidative stress following traumatic brain injuries. Potential therapeutic effects of nanowired cerebrolysin. Brain Injury 2016. 

Muresanu DF, Sharma A, Patnaik R, Nozari A, Tian ZR, Ozkizilcik A, Moessler H, Sharma HS. Nanodelivery of cerebrolysin induces profound neuroprotection in heat stroke following chronic hypertension in combination with carbon nanoparticles induced exacerbation of brain damage. Brain Injury 2016. 

Jemna N, Rosu O, Isip OC, Tincau OA, Cruceanu O, Blesneag AV, Muresanu DF. Spontaneus carotid- cavernous sinus fistula - Case report. Clujul Medical 2016. 

Blesneag AV, Popa L, Stan AD. Non-invasive brain stimulation in early rehabilitation after stroke. J Med Life 2015.

Blesneag AV, Slavoaca DF, Popa L, Stan AD, Jemna N, Isai Moldovan F, Muresanu DF. Low-frequency rTMS in patients with subacute ischemic stroke: clinical evaluation of short and long-term outcomes and neurophysiological assessment of cortical excitability. J Med Life 2015.

Ruozi B, Belletti D, Sharma HS, Sharma A, Muresanu DF, Mössler H, Forni F, Vandelli MA, Tosi G. PLGA Nanoparticles Loaded Cerebrolysin: Studies on Their Preparation and Investigation of the Effect of Storage and Serum Stability with Reference to Traumatic Brain Injury. Molecular Neurobiology 2015. DOI:10.1007/s12035-015-9235-x

Sharma HS, Kiyatkin EA, Patnaik R, Lafuente JV, Muresanu DF, Sjöquist PO, Sharma A. Exacerbation of Methamphetamine Neurotoxicity in Cold and Hot Environments: Neuroprotective Effects of an Antioxidant Compound H-290/51. Molecular Neurobiology 2015. DOI:10.1007/s12035-015-9252-9

Muresanu DF, Sharma A, Lafuente JV, Patnaik R, Tian ZR, Nyberg F, Sharma HS. Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord. Molecular Neurobiology 2015. DOI:10.1007/s12035-015-9298-8

Sharma A, Muresanu DF, Lafuente JV, Patnaik R, Tian ZR, Buzoianu AD, Sharma HS. Sleep Deprivation-Induced Blood-Brain Barrier Breakdown and Brain Dysfunction are Exacerbated by Size-Related Exposure to Ag and Cu Nanoparticles. Neuroprotective Effects of a 5-HT(3) Receptor Antagonist Ondansetron. Molecular Neurobiology 2015. DOI:10.1007/s12035-015-9236-9

Sharma HS, Muresanu DF, Lafuente JV, Sjöquist PO, Patnaik R, Sharma A. Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51. Molecular Neurobiology 2015. DOI:10.1007/s12035-015-9297-9

Stanca DM, Mărginean IC, Soritău O, Dragos C, Mărginean M, Muresanu DF, Vester JC, Rafila A. GFAP and antibodies against NMDA receptor subunit NR2 as biomarkers for acute cerebrovascular diseases. Journal of Cellular and Molecular Medicine 2015. DOI:10.1111/jcmm.12614

Muresanu DF, Ciurea AV, Gorgan RM, Gheorghita E, Florian SI, Stan H, Blaga A, Ianovici N, Iencean SM, Turliuc D, Davidescu HB, Mihalache C, Brehar FM, Mihăescu AS, Mardare DC, Anghelescu A, Chiparus C, Lapadat M, Pruna V, Mohan D, Costea C, Costea D, Palade C, Bucur N, Figueroa J, Alvarez A. A retrospective, multi-center cohort study evaluating the severity-related effects of Cerebrolysin treatment on clinical outcomes in traumatic brain injury. CNS and Neurological Disorders - Drug Targets 2015. DOI:10.2174/1871527314666150430162531

Molnar A, Beyer R, Florian S, Mureşanu DF, Trifan C, Mureşan I, Săcui D, Scridon T, Bălănescu RN. Drainage of cerebral abscesses prior to valve replacement in stable patients with acute left-sided infective endocarditis. CNS and Neurological Disorders - Drug Targets 2015. DOI:10.2174/1871527314666150317224921

Sharma A, Muresanu D, Moessler H, Lafuente JV, Sharma HS. Sleep deprivation exacerbates pathophysiology of concussive head injury: Neuroprotective effects of a multimodal drug cerebrolysin. Journal of Head Trauma Rehabilitation 2015. 

Sharma HS, Muresanu DF, Ryan Tian Z, Ozkizlicik A, Lafuente JV, Moessler H, Sharma A. TIO2 nanowired cerebrolysin attenuates overexpression of ubiquitin and nitric oxide synthase and induces neuroprotection following spinal cord trauma. Journal of Head Trauma Rehabilitation 2015. 

Popa L, Selejan O, Scott A, Mureşanu DF, Balea M, Rafila A. Reading beyond the glance: eye tracking in neurosciences. Neurological Sciences 2015. DOI:10.1007/s10072-015-2076-6

Poon W, Vos P, Muresanu D, Vester J, Von Wild K, Hömberg V, Wang E, Lee TMC, Matula C. Cerebrolysin asian pacific trial in acute brain injury and neurorecovery: Design and methods. Journal of Neurotrauma 2015. DOI:10.1089/neu.2014.3558

Sharma HS, Feng L, Lafuente JV, Muresanu DF, Tian ZR, Patnaik R, Sharma A. TiO2-nanowired delivery of mesenchymal stem cells thwarts diabetes- Induced exacerbation of brain pathology in heat stroke: An experimental study in the rat using morphological and biochemical approaches. CNS and Neurological Disorders - Drug Targets 2015. DOI:10.2174/1871527314666150318114335

Sharma HS, Muresanu DF, Tian ZR, Ozkizlicik A, Lafuente JV, Moessler H, Sharma A TiO2 Nanowired Cerebrolysin Attenuates Overexpression of Ubiquitin and Nitric Oxide Synthase and Induces Neuroprotection Following Spinal Cord Trauma JOURNAL OF HEAD TRAUMA REHABILITATION 2015

Brainin M, Muresanu D, Slavoaca D. 2nd International Salzburg Conference on Neurorecovery (ISCN 2013) Salzburg/Austria|November 28th-29th, 2013. J Med Life 2014. 

Bajenaru O, Roceanu AM, Albu S, Zainea V, Pascu A, Georgescu MG, Cozma S, Marceanu L, Muresanu DF. Effects and tolerability of betahistine in patients with vestibular vertigo: results from the Romanian contingent of the OSVaLD study. Int J Gen Med 2014. DOI:10.2147/IJGM.S71015

Alvarez A, Iglesias O, Aleixandre M, Linares C, Figueroa J, Muresanu D, Moessler H. Cerebrolysin and combination therapy enhance serum bdnf in ad patients. Alzheimer's and Dementia 2014. 

Sharma A, Muresanu DF, Patnaik R, Prasad V, Sharma HS. Anaesthetics influence closed head injury induced blood-brain barrier disruption, cerebral blood flow, brain oedema and brain pathology. Brain Injury 2014. 

Sharma HS, Muresanu DF, Patnaik R, Moessler H, Sharma A. Traumatic brain injury induced blood-brain barrier disruption, brain oedema formation and brain pathologies are reduced by cerebrolysin in a dose-dependent manner. An experimental study in the rat using biochemical and morphological approaches. Brain Injury 2014. 

Sharma HS, Muresanu DF, Vannemreddy P, Patnaik R, Sharma A. Cold and hot environment exacerbates brain pathology following concussive brain injury. Brain Injury 2014. 

Feng L, Sharma A, Muresanu DF, Moessler H, Sharma HS. Engineered nanoparticles from metals aggravate spinal cord injury induced neuropathic pain syndrome and exacerbate blood-spinal cord barrier breakdown, astrocytic activation and neural injury: Neuroprotective effects of cerebrolysin. Brain Injury 2014. 

Rakusa M, Gak S, Alekseenko Y, Ehler E, Muresanu D, Opara J, Vos P. Can young European neurologists comfortably manage patients with traumatic brain, spine or nerve injuries (TBI)?. Neurology 2014. 

Sharma H, Muresanu DF, Sharma A. 13(th) international congress on amino acids, peptides and proteins (ICAPP); neurobiology Symposium, October 5-7, 2013; Galveston TX, USA. CNS and Neurological Disorders - Drug Targets 2014. DOI:10.2174/187152731301140210114550

Bianchi S, Di Palma C, Gallus GN, Taglia I, Poggiani A, Rosini F, Rufa A, Muresanu DF, Cerase A, Dotti MT, Federico A. Two novel htra1 mutations in a european carasil patient. Neurology 2014. DOI:10.1212/WNL0000000000000202

Vacaras V, Zsigmond Major Z, Seewooram R, Andrea Major K, Fior Muresanu D, Dana Buzoianu A. Disease activity and disability evolution under glatiramer acetate: A clinical approach. Neuropsychopharmacologia Hungarica 2014.  

Sharma HS, Menon PK, Lafuente JV, Aguilar ZP, Wang YA, Muresanu DF, Mössler H, Patnaik R, Sharma A. The role of functionalized magnetic iron oxide nanoparticles in the central nervous system injury and repair: new potentials for neuroprotection with Cerebrolysin therapy.. Journal of nanoscience and nanotechnology 2014. DOI:10.1166/jnn.2014.9213

Muresanu DF, Popa-Wagner A, Stan A, Buga A-M, Popescu BO. The vascular component of alzheimer's disease. Current Neurovascular Research 2014. DOI:10.2174/1567202611666140408105333

Bulboaca A, Ursu C, Stanescu I, Muresanu D, Bulboaca A. Visual pathways involvement in multiple sclerosis from pathological process to neuro-ophthalmologic assessment. Romanian Journal of Neurology/ Revista Romana de Neurologie 2014. 

Vacaras V, Major ZZ, Mureşanu DF, Krausz TL, Mǎrginean I, Buzoianu DA. Effect of glatiramer acetate on peripheral blood brain-derived neurotrophic factor and phosphorylated TrkB levels in relapsing-remitting multiple sclerosis. CNS and Neurological Disorders - Drug Targets 2014. DOI:10.2174/1871527313666140618110049

Perju-Dumbrava L, Muntean M-L, Mureşanu DF. Cerebrovascular profile assessment in Parkinson's disease patients. CNS and Neurological Disorders - Drug Targets 2014. DOI:10.2174/1871527313666140618110409

Roceanu A, Muresanu DF, Popescu BO, Anghel D, Georgescu M, Cozma S, Marceanu L, Albu S, Bajenaru O. Taking history for vertigo and dizziness – A practical approach. Romanian Journal of Neurology/ Revista Romana de Neurologie 2014.  

Sharma HS, Menon P, Lafuente JV, Muresanu DF, Tian ZR, Patnaik R, Sharma A. Development of in vivo drug-induced neurotoxicity models. Expert Opinion on Drug Metabolism and Toxicology 2014. DOI:10.1517/17425255.2014.970168

Ruozi B, Belletti D, Forni F, Sharma A, Muresanu D, Mössler H, Vandelli MA, Tosi G, Sharma HS. Poly (D,L-Lactide-co-Glycolide) nanoparticles loaded with cerebrolysin display neuroprotective activity in a rat model of concussive head injury. CNS and Neurological Disorders - Drug Targets 2014. DOI:10.2174/1871527313666140806145540

Huang H, Sun T, Chen L, Moviglia G, Chernykh E, von Wild K, Deda H, Kang K-S, Kumar A, Jeon SR, Zhang S, Brunelli G, Bohbot A, Soler MD, Li J, Cristante AF, Xi H, Onose G., Kern H, Carraro U, Saberi H, Sharma HS, Sharma A, He X, Muresanu D, Feng S, Otom A, Wang D, Iwatsu K, Lu J, Al-Zoubi A. Consensus of clinical neurorestorative progress in patients with complete chronic spinal cord injury. Cell transplantation 2014. DOI:10.3727/096368914X684952